NDC 68135-673 – Palynziq

Pegvaliase 20 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC68135-673

Product details

Brand name
Palynziq
Generic name
Pegvaliase-pqpz
Labeler
BioMarin Pharmaceutical Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761079
Marketed since
May 24, 2018
Listing expires
December 31, 2027
Pharmacologic class
Phenylalanine Metabolizing Enzyme

Active ingredients

Uses, dosage, side effects and warnings for Palynziq →

Package NDC codes (2)

Package NDCDescriptionSince
68135-673-401 SYRINGE in 1 CARTON (68135-673-40) / 1 mL in 1 SYRINGE (68135-673-39)May 24, 2018
68135-673-4510 SYRINGE in 1 CARTON (68135-673-45) / 1 mL in 1 SYRINGE (68135-673-39)May 24, 2018

Other Palynziq products